Lipocine (LPCN) News Today → 25% of Americans Are In Grave Danger (From Banyan Hill Publishing) (Ad) Free LPCN Stock Alerts $6.95 -0.10 (-1.42%) (As of 11:38 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | americanbankingnews.comLipocine (NASDAQ:LPCN) Shares Pass Above 50 Day Moving Average of $5.29May 28, 2024 | investorplace.com7 Penny Biotech Stocks to Triple Your InvestmentMay 9, 2024 | investorplace.comLPCN Stock Earnings: Lipocine Beats EPS for Q1 2024May 9, 2024 | finance.yahoo.comLipocine Announces Financial Results for the First Quarter Ended March 31, 2024May 8, 2024 | prnewswire.comLipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024May 1, 2024 | prnewswire.comLipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154April 12, 2024 | msn.comLipocine hopes obesity drug could boost muscle mass in combo with GLP1-RAsApril 11, 2024 | finanznachrichten.deLipocine Inc.: Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityApril 11, 2024 | fr.investing.comLipocine annonce les résultats positifs d'une étude sur le traitement de l'obésitéApril 11, 2024 | markets.businessinsider.comLipocine Reports Positive Phase 2 Results For LPCN 2401 In Participants With ObesityApril 11, 2024 | finance.yahoo.comLipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityApril 11, 2024 | prnewswire.comLipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityMarch 28, 2024 | finanznachrichten.deLipocine Inc.: Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with CirrhosisMarch 28, 2024 | markets.businessinsider.comLipocine: LPCN 1148 Meets Primary And Hepatic Encephalopathy Endpoints In Phase 2 StudyMarch 28, 2024 | prnewswire.comLipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with CirrhosisMarch 25, 2024 | finance.yahoo.comCirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsightMarch 25, 2024 | prnewswire.comLipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154March 7, 2024 | investorplace.comLPCN Stock Earnings: Lipocine Beats EPS for Q4 2023March 7, 2024 | seekingalpha.comLipocine GAAP EPS of -$3.14March 7, 2024 | prnewswire.comLipocine Announces Financial Results for the Full Year Ended December 31, 2023March 6, 2024 | finance.yahoo.comLipocine to Present at 36th Annual Roth ConferenceFebruary 6, 2024 | finance.yahoo.comLipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154February 2, 2024 | finanznachrichten.deLipocine Inc.: Lipocine Announces Continued Commercialization of TLANDO through Verity PharmaceuticalsFebruary 2, 2024 | fr.investing.comLipocine transfère la commercialisation de TLANDO à Verity PharmaFebruary 2, 2024 | finance.yahoo.comLipocine Announces Continued Commercialization of TLANDO® through Verity PharmaceuticalsJanuary 18, 2024 | marketwatch.comLipocine Shares Rise Premarket on Tlando Licensing DealJanuary 18, 2024 | msn.comLipocine licenses Tlando testosterone therapy to Verity PharmaJanuary 18, 2024 | markets.businessinsider.comLipocine Signs TLANDO Franchise License Deal With Verity PharmaJanuary 18, 2024 | finance.yahoo.comLipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and CanadaDecember 19, 2023 | finance.yahoo.comLipocine to Present at Biotech Showcase 2024November 22, 2023 | msn.comLipocine files for $150M mixed shelfNovember 13, 2023 | marketwatch.comLipocine to Share Cirrhosis Treatment LPCN 1148 Results at The Liver MeetingNovember 13, 2023 | finance.yahoo.comLipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023November 10, 2023 | markets.businessinsider.comBuy Rating for Lipocine: Anticipation of Successful LPCN 1154 Study and Strong Financial PositionNovember 8, 2023 | finance.yahoo.comLipocine Announces Financial Results for the Third Quarter Ended September 30, 2023November 5, 2023 | morningstar.comLipocine Inc LPCNNovember 1, 2023 | finance.yahoo.comLipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023October 26, 2023 | finance.yahoo.comLipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum DepressionOctober 23, 2023 | finance.yahoo.comLipocine to Present at the H.C. Wainwright Annual NASH Investor ConferenceSeptember 19, 2023 | finance.yahoo.comLipocine to Present at the Cantor Fitzgerald Global Healthcare ConferenceAugust 17, 2023 | stocknews.comLooking for a Value Investment? Check out These 3 Pharma StocksAugust 16, 2023 | finance.yahoo.comLPCN: Trial Results Improve OutlookAugust 10, 2023 | finance.yahoo.comLipocine Announces Financial Results for the Second Quarter Ended June 30, 2023July 31, 2023 | finance.yahoo.comLPCN: 1148 Shows Muscle Loss ReversalJuly 27, 2023 | benzinga.comWhy Lipocine Stock Is Moving Higher Today?July 27, 2023 | investorplace.comWhy Is Lipocine (LPCN) Stock Up 32% Today?June 14, 2023 | finance.yahoo.comLipocine to Present at H.C. Wainwright Annual Neuropsychiatry Virtual ConferenceJune 7, 2023 | finance.yahoo.comLipocine to Present LPCN 1148 and LPCN 1144 at the EASL Congress 2023May 16, 2023 | msn.comLipocine stock dips after bridging study data of LPCN 1154 for postpartum depressionMay 16, 2023 | finance.yahoo.comPositive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine's Oral Candidate for Rapid Relief of Depression Get Lipocine News Delivered to You Automatically Sign up to receive the latest news and ratings for LPCN and its competitors with MarketBeat's FREE daily newsletter. Email Address Was the Great Financial Crisis fun? (Ad)The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, was terrible! The majority of market indexes lost over 50% of their value. Almost every day, traders would look at their trading accounts and just see a sea of red. Get those kind of results during the Great Financial Crisis, without having to study more LPCN Media Mentions By Week LPCN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LPCN News Sentiment▼0.670.69▲Average Medical News Sentiment LPCN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LPCN Articles This Week▼00▲LPCN Articles Average Week Get Lipocine News Delivered to You Automatically Sign up to receive the latest news and ratings for LPCN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ORGS News LPTX News TNXP News LTRN News RPTX News VERU News SCPH News RGLS News SYRS News RAPT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LPCN) was last updated on 6/6/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredEverything from semiconductors to space shuttles depend on this overlooked mineralBoron is also at the heart of a breakthrough that could fuel one of mankind's most sensational advances in sem...Capital Trends | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits | Sponsored